Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Period	fcf
2015-12-31	-$23.16M
2016-12-31	-$6.20M
2017-12-31	-$36.02M
2018-12-31	-$126.50M
2019-12-31	-$72.50M
2020-12-31	-$82.50M
2021-12-31	-$180.00M
2022-12-31	-$38.30M
2023-12-31	$36.50M
2024-12-31	$296.30M

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PODD	$204.31	+0.00%	0.89M
3
4
5

Insulet Corporation (PODD) Free Cash Flow

Free Cash Flow Data

Get Insulet Corporation Data in Excel

More PODD Financial Data